Inventiva’s lanifibranor has been tipped to become a blockbuster in the liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a trial.

David Edwards has spent over a decade reporting on social justice, human rights and politics for Raw Story. He also writes Crooks and Liars. He has a background in enterprise resource planning and ...

The Kansas City Chiefs passed on remaking their wide receiver room early in the offseason, instead deciding to double down on their current options. Rashee Rice returning should elevate the offense in ...

Jay Manuel and Pamela Chavez's zest for life is immediately apparent while watching their new TLC reality series, "Jay & Pamela." But Jay is the first to admit that he hasn't always had an easy ...

The accused killer's lawyer calls the Justice Department's decision 'barbaric.' Pool/ABACA/Shutterstock; CURTIS MEANS/POOL/EPA-EFE/Shutterstock U.S. Attorney General ...

Motherwell, Wishaw and Carluke MP Pamela Nash has welcomed the rise in the new National Living Wage and National Minimum Wage rates. Full-time workers on the National Living Wage will see a real-terms ...

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US “After careful consideration, I have ...